A bill to require the Science and Technology Directorate in the Department of Homeland Security to develop greater capacity to detect and identify illicit substances in very low concentrations.
About This Bill
Committee
Latest Action · December 4, 2024
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
This bill directs the Department of Homeland Security's Science and Technology Directorate to develop improved equipment and technology for detecting dangerous drugs like fentanyl and xylazine in very small concentrations. The legislation focuses on creating portable detection devices that require minimal handling of samples, equipment that can separate drugs from cutting agents, and systems using artificial intelligence to identify new drug variants not yet in existing reference databases. The bill requires coordination with the Drug Enforcement Administration and mandates that research priorities be based on current threat assessments from DHS and DEA. The law also requires the agency to follow safety and ethical guidelines from the National Institute of Standards and Technology when developing these artificial intelligence tools. This legislation affects federal, state, local, tribal, and territorial law enforcement agencies that would use these new detection technologies in the field.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.